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Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
Very few patients with familial hypomagnesemia, hypercalciuria and
nephrocalcinosis have been described. Information about clinical course,
familial studies or evolution after renal transplantation is very scant. We
have studied eight patients with this syndrome who belong to five different
families. The mean age at diagnosis was 15 7years (5 to 25 years). The
primary clinical data were polyuria-polydipsia (8 cases), ocular abnormal-
ities (5), recurrent urinary tract infections (5) and recurrent renal colics
with stone passage (2). Bilateral nephrocalcinosis was observed in all
cases. Every patient showed hypomagnesemia (1.1 0.2 mg/dl) with
inappropriately high urinary magnesium (Mg) excretions (70 17 mg/
day), Mg clearances (4.4 1.2 mI/rn) and Mg fractional excretions (16.2
7.1%). Hypercalciuria was present in e'ery case except in those with
advanced renal insufficiency. Serum parathormone levels were abnormally
high. Serum calcium (Ca), hosphorus and potassium, and urinary excre-
tions of uric acid and oxalate were normal. Neither chronic oral Mg
administration nor thiazide diuretics normalized serum Mg levels or
urinary Ca excretions, respectively. Follow-up was 6 4.5 years. penal
function worsened in every case with six patients starting on chronic
dialysis after 4.3 3.8 years. The progression rate of renal insufficiency
correlated with the severity of nephrocalcinosis. Five patients have
received a kidney graft, and their serum Mg and urinary Ca have always
been within normal values after transplantation. Twenty-six members of
four of the affected families were studied: none of them showed hypo-
magnesemia, renal insufficiency or nephrocalcinosis. However, eleven
cases (42%) had hypercalciuria and four of them presented with recurrent
renal stones. Two family members had medullary sponge kidneys. In
conclusion, progression to renal insufficiency is common in this syndrome;
oral Mg and thiazide diuretics are ineffective to correct abnormalities.
After kidney graft; tubular handling of Mg and Ca was normal. A striking
incidence (42%) of hypercalciuria was found in the familial study.
Very few patients with the syndrome of familial hypomag-
nesemia, hypercalciuria and nephrocalcinosis have been described
[1—8]. The cardinal characteristics of this syndrome include renal
magnesium (Mg) wasting with persistent hypomagnesemia unre-
sponsive to Mg administration, marked hypercalciuria, nephrocal-
cinosis and renal insufficiency. Data suggest the existence of a
disorder in the reabsorption of Mg and calcium (Ca) in the thick
ascending limb of the loop of Henle [8]. This syndrome should be
distinguished from other hereditary causes of hypomagnesemia,
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such as familial isolated hypomagnesemia or familial hypomag-
nesemia with hypokaliernia [8, 9].
Information about the long-term evolution of these patients is
very scarce. Although most of the reported cases had renal
insufficiency, no data about the progression of renal failure or the
evolution after renal transplantation have been described. In this
study we present the clinical and biochemical data of eight
patients belonging to five different families. Long-term evolution
and the response to several treatments are also described. Five
patients who developed end-stage renal failure received a kidney
graft; sustained normality of Mg and Ca handling by grafted
kidneys was observed throughout the post-transplant follow-up. In
addition, we present data obtained in 26 members of the affected
families. Although no other cases of nephrocalcinosis or renal
insufficiency were identified, a striking incidence of hypercalciuria
(42%) was observed.
Methods
Eight patients with the syndrome of hypomagnesemia and renal
Mg wastiiig, hypercalciuria and nephrocalcinosis, were identified
in our Departments in the period of 1982 to 1990. Patients were
referied for evaluation because of detection of renal insufficiency
in three cases, urinary tract infection in two, renal lithiasis in two
and polyuria/polydipsia in one. Physical examination included an
ophtalmological study in every case. General serum biochemistry,
including glucose, creatinine, uric acid, phosphate, Ca, sodium,
potassium, chloride, bicarbonate, and arterial blood gases was
obtained in every patient. Serum Mg, serum parathormone,
urinary excretions of Mg, Ca, phosphate and uric acid, protein-
uria, glucosuria and urinary sediment were also determined. X-ray
films of thorax and abdomen, abdominal echographies and radio-
logical bone examinations were performed in all the patients.
After the initial diagnosis, patients were followed in our outpa-
tient clinic. Routine general biochemistry, serum Mg, and urinary
excretions of Mg, Ca, phosphate and uric acid were measured at
every visit. Mean follow-up between diagnosis and last visit or
onset of chronic dialysis, was 6 4.5 years (I to 11 years).
Six patients started on chronic hemodialysis after ito 10 (mean
4.3 3.8) years of follow-up. Five of them received a cadaveric
kidney transplant after 3 to 120 months (36 47) on hemodial-
ysis. Immunosuppressive treatment consisted of steroids plus
cyclosporine in every case. In addition to routine biochemistry,
serum and urinary Mg and urinary excretions of Ca, phosphate
and uric acid were measured at every visit.
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Table 1. Clinical characteristics
Polyuria/ Urinaiy
Patient Age/sex polydipsia infections
Stone Ocular Tetany/
passage abnormalities convulsions Hypertension Gout
1 5/F + — — — — — —
2 9/F + — Cornea! calcifications, —
nystagmus
— —
3 10/F + + + Coriorretinitis, nystagmus — — —
4 17/F + + — Myopia — — —
5 24/M + — — Myopia, nystagmus — — —
6 25/F + + + Nystagmus — — —
7 22/M + + — — — —
8 10/F + — — — -1- —
Age is the patient's age at the diagnosis (years).
Table 2. Biochemical data at diagnosis
Serum Magnesium Phosphate
Serum Creatinine uric Serum Urinary Magnesium fractional Urinary tubular
creatinine clearance acid magnesium magnesium clearance excretion calcium PTH reabsorption
Patient mg/dl mt/mm mg/dl mg/dl mg!24 hr mt/mm % mg/kg/day pg/mt %
1 0.7 121 7.2 1 59 6.5 11.3 13.2 602 86
2 1.1 73 9.8 0.9 66 5 13.2 12 1140 60
3 0.9 88 8.1 1.2 80 3.9 8.1 8 795k 72
4 8.2 11 7.2 1.6 64 2.6 24 2.9 2500 21
5 8.1 10 9.1 1.2 39 3.4 27 0.5 264b 38
6 1.4 55 10.3 1.1 85 4.1 9.6 6 485 51
7 5.3 14 7.2 1.3 94 4.3 22 1.5 303k ND
8 1.2 33 6 1.2 75 5.9 14.6 6.8 ND NDMean±s 3.3±3 50±40 8.1±1.4 1.1±0.2 70±17 4.4±1.2 16.2±7.1 6.3±4.6 54±23
ND is not done.
a Carboxy-terminal (normal value <300 pg/rn!)b Intact PTH (normal value <60 pg/mI)
The eight patients belonged to five different families. Twenty-
six members of four of these families participated in the following
study: medical history (inquiring about antecedents of renal
stones, urinary tract infections, polyuria-polydipsia or ocular
abnormalities), complete physical examination, and general bio-
chemistry (including serum creatinine, glucose, uric acid, Ca, Mg,
phosphate, sodium, potassium, chloride, bicarbonate and urinary
excretions of calcium, uric acid, phosphate and Mg). In addition,
an X-ray film of the abdomen was performed in every case.
Both serum and urinary Ca and Mg were measured by atomic
absorption spectrophotometry. Serum parathormone concentra-
tions were determined with a radioimmunoassay kit using an
antiserum directed at the carboxy-terminal region (normal range
60 to 300 pg/mI; Nichols, CA, USA). Since 1989, intact parathor-
mone has been determined with an intact hormone radioimmu-
noassay (normal range 10 to 60 pg/mi; CIS, France). Standard
autoanaiyzer methods were used to measure the remaining gen-
eral biochemistry. Fractional excretion of Mg was calculated as:
Urinary Mg X serum creatinine
Serum Mg X urinaiy creatinine
Statistical analysis were performed by Student's t-test and the
chi-square test. Values are expressed as mean standard devia-
tion.
Results
Clinical and biochemical data
Age at diagnosis was 15 7 years (range 5 to 25; Tables 1 and
2). There were six females and two males. Every patient reported
having polyuria and polydipsia from their first years of life. Five
patients had recurrent urinary tract infections and two had passed
renal stones. Ocular abnormalities were present in five cases:
horizontal nystagmus in four, severe myopia in two, corneal
calcifications in one and coriorretinitis in one. No patient pre-
sented with tetany, convulsions, or gouty arthritis. Only one case
(patient 8) had arterial hypertension. With these exceptions,
physical examinations were normal; body growth and mental
development were normal in every case.
Three patients (cases 4,5,7) presented with advanced renal
insufficiency at diagnosis. Serum Mg was low in every case (mean
1.1 0.2 mg/dl; range 0.9 to 1.6) including the cases with renal
insufficiency. Despite the presence of hypomagnesemia, urinary
Mg excretion was inappropriately high in all cases (70 17
mg/day), with increased values of Mg clearance and Mg fractional
excretion (Table 2). Urinary Ca was abnormally high (6.3 4.6
mg/kg/day) except in patients with renal insufficiency. Urinary uric
acid excretion (322 159 mg/day) and oxaluria (22.5 7 mg/day)
were within normal values in every case.
x 100
Fig. 2. Evolution of semm magnesium.
Table 3. Evolution of urinary calcium excretion (mg/kg/day) with
thiazide treatment
Patient
Month of treatment
0 3 6 9 12 15
1 (first treatment) 14.5 9.6 10 13.5
1 (second treatment) 8.7 11.7 4.3 9.1 6 8
2 12 4.8 10
Fig. 1. Severe bilateral nephrocalcinosis. Abdominal X-ray film of patient
2 at diagnosis (age 9 years).
Serum uric acid levels were increased in all the patients, even in
those with normal renal function (Table 2). Parathormone levels
were also increased in all patients independently of their renal
function (Table 2). Levels of serum Ca (8.6 1.3 mg/dl),
phosphate (5.2 1.5 mg/dl), sodium (140 3.6 mEq/liter),
potassium (4.3 0.5 mEq/liter) and glucose were normal, al-
though those patients with renal insufficiency showed a tendency
towards hypocalcemia, hyperphosphoremia and hyperkalemia.
Acid-base equilibrium was normal except in the three cases with
renal impairment, who presented with mild metabolic acidosis.
Proteinuria was negative with the exception of the cases with
renal failure that showed proteinuria between 2 to 3 g/day.
Glucosuria was always negative.
Radiological findings
Abdominal x-ray films showed nephrocalcinosis in every patient
(Fig. 1). In addition, patients 4, 5 and 7, who had renal insuffi-
ciency, presented with a decrease of their renal size. Renal
echographies confirmed the nephrocalcinosis. Bone subperiosteal
resorption was observed in the cases with renal failure. No other
osteo-articular abnormalities were observed.
Effects of treatment
Patients were maintained on normal diets. When serum creat-
mine was greater than 3 mg/dl, low protein diets (40 to 60 g/day)
were advised. All the patients were treated with oral Mg 140 to
400 mg/daily. Mg supplements were administered in the form of
tablets of Mg oxide. Although there was a tendency to increase,
serum Mg remained below normal levels throughout the evolution
of the study (Fig. 2). Patients 1 (on 2 occasions) and 2 were
treated with hydrochlorothiazide (50 to 100 mg daily) for 6 to 15
months. No sustained reductions in urinary Ca excretions were
observed (Table 3) and there were no changes in serum Mg or
urinary Mg excretions. Calciuria remained persistently increased
in all the patients; only some of them, when their renal function
was severely impaired, showed normal (<4 mg/kg/day) calcium
excretions. Patients 1, 2 and 3 received oral citrate solutions from
the fifth, fourth and third year of follow-up, respectively. In
patient 1, who had a stable renal function (Fig. 3), oral citrate was
withdrawn in the ninth year of follow-up, without further deteri-
oration of renal function. In patients 2 and 3 oral citrate was
maintained until their start on chronic dialysis.
Evolution of renal function
Renal function worsened in every case, although with different
progression rates (Fig. 3). Three patients (cases 4,5,7), who
presented with advanced renal insufficiency at diagnosis, were on
chronic dialysis within the first year of follow-up. Of the five
remaining cases, three (cases 2,3 and 6) showed a progressive
worsening of renal function, reaching chronic dialysis after 7 to 10
years. Only two patients (cases I and 8) persist without dialysis
after 11 and 9 years of follow-up, respectively, although both
patients show mild renal insufficiency. There were no clinical or
biochemical differences between these patients and those who
evolved into chronic dialysis. However, the severity of radiological
nephrocalcinosis was remarkably lesser at diagnosis and through-
out the study in the two patients with more favorable evolution of
disease.
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Table 4 Evolution after renal transplantation
Patient
Follow-up
months
Serum
creatinine
Serum
magnesium Magnesium
clearance
mi/mm
Magnesium
fractional
excretion
%
Urinary
calcium
mg/kg/daymg/dl
2 36 1.1 0.3 2 0.3 2.8 0.2 4.3 0.2 1.5 0.2
3 ia 1.6 2 ND ND ND
4 9 1.4 0.4 2 0.3 1.5 0.7 3.2 0.3 0.8 0.2
5 16 1.3 0.4 2.2 0.4 5.6 1.2 8.1 0.6 3.1 0.2
7 12 2.7 0.7 2.2 0.2 5.5 1.4 9.2 0.4 1.8 0.1
Values expressed are the mean SD of all the measurements obtained after the first month of renal transplantation.
a Acute vascular rejection, returning to dialysis
Evolution after renal transplantation
Five patients (cases 2,3,4,5 and 7) received a cadaveric kidney
graft after 36 47 (3 to 120) months on hemodialysis. In every
measurement after renal transplantation, normal values of serum
Mg (>1.8 mg/dl) and urinary calcium excretion (<4 mg/kg/day)
were observed in all these cases (Table 4).
Familial study
The eight patients belong to five different families. Twenty-six
members of four of these families were studied (Fig. 4). None of
them showed renal insufficiency, nephrocalcinosis or renal lithia-
sis; however, 11(42%) of these family members had hypercal-
ciuria and four of them had history of recurrent renal stones. Only
two family members presented mild hypomagnesemia (serum Mg
1.5 and 1.6 mg/dl); both of them showed hypercalciuria, but
without nephrocalcinosis or renal insufficiency. No ocular abnor-
malities were observed. There were no differences other than
urinary calcium between hypercalciuric and normocalciuric family
members (Table 5).
We revised the intravenous urographies that have been per-
formed several years before in two of the studied family members
who were diagnosed hypercalciuria and had history of renal
lithiasis. Although no lithiasis were seen, ectatia of collecting
ducts, characteristic of medullaiy sponge kidneys (MSK), was
evident in both cases (Fig. 5).
Discussion
The thick ascending limb of Henle's loop is the major site of Mg
reabsorption in the renal tubule [10]. Data suggest that the
primary abnormality in patients with the syndrome of familial
hypomagnesemia, hypercalciuria and nephrocalcinosis is a defect
in Mg and Ca reabsorption at this level [8]. The consequence is a
sustained and severe renal Mg wasting, accompanied by hypercal-
ciuria. By contrast, tubular handling of potassium and chloride is
normal, and thus, no hypokalemia is observed in this entity. The
absence of hypokalemia establishes the difference with Bartter's
syndrome, in which hypomagnesemia is frequently observed but
that always presents hypokalemia. Gitelman's syndrome, another
tubular disorder of Mg reabsorption, is also characterized by
hypokalemia [11].
The clinical and biochemical characteristics of our patients are
similar to previously reported cases (Tables 1 and 2). Polyuria-
polydipsia, ocular abnormalities (severe myopia, nistagmus,
coloboma, coriorretinitis), recurrent urinary tract infections and
renal lithiasis were the most common clinical findings. In addition,
tetany, seizures, chondrocalcinosis, rickets, arterial hypertension
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Fig. 4. Pedigrees of the four studied families.
Symbols are: (E) males; (0) females; (U, •)
males or females with the syndrome of
hypomagnesemia, hypercalciuria and
nephrocalcinosis. Numbers on the left of these
patients correspond with patient's number in
Tables 1-4; (I) hypercalciuria; (\) hystory of
renal lithiasis; (+) studied family members(N = 26).
and gouty arthritis have been described in other previously
reported cases [1—8]. All our patients showed hyperuricemia
(Table 2), although none of them presented gouty arthritis. Only
one of our patients showed arterial hypertension at diagnosis.
Neither chondrocalcinosis nor rickets were observed in bone
radiographs, and no patient reported previous episodes of tetany
or seizures.
The cardinal biochemical findings were severe hypomag-
nesemia and hypercalciuria. Hypomagnesemia, with inappropri-
ately high urinary Mg excretion, was present even in cases with
advanced renal failure. Normal values for serum Mg are 1.8 to 3
mg/dl, with urinary Mg excretions around 100 mg/day and Mg
fractional excretions of 3 to 5%. Our patients presented a serum
Mg level of 1.1 0.2 mg/dl, at the initial diagnosis, with urinary
Mg excretions of 70 17 mg/day and Mg fractional excretions
of 16.2 7.1% (Table 2). For such a severe hypomagnesemia
(1.1 mg/dl), urinary Mg excretions lower than 15 mg/day and Mg
fractional excretions lower than 0.5% should be expected in
subjects with an adequate renal handling of Mg (for example in
severe nonrenal Mg losses or in normal subjects submitted to
extreme dietary restrictions of Mg) [12].
Oral administration of Mg was unable to compensate renal Mg
losses in our patients. Consequently, they showed sustained
hypomagnesemia throughout their clinical course. Only when they
reached advanced renal insufficiency did the serum Mg approach
the lower limits of normality (Fig. 2). Similarly, hypercalciuria did
not respond to thiazide diuretics: urinary calcium did not show
any consistent reduction in patients I and 2, who were treated
with hydrochlorothiazide for more than six months (Table 3). This
lack of response contrasts with the usual reduction of urinary
calcium by thiazide diuretics in patients with idiopathic hypercal-
ciuria, in which diuretics are one of the cornerstones of treatment
[131.
Serum PTH was remarkably elevated in our patients, even in
D Family 4
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Table 5. Family members
Family Family
Total family members members
members with without
studied hypercalciuria hypercalciuria(N=26) (N11) (N=15)
Serum creatinine 0.9 0.1 0.9 0.1 1 0.1
mg/dl
Serum magnesium 2.2 0.3 2.2 0.5 2.2 0.1
mg/dl
Magnesium clearance 3.3 1.7 3.3 1.6 3.3 1.8
mum
Magnesium fractional 4.6 2.1 5.4 2.4 4 1.8
excretion %
Urinary calcium 3.2 1.7 5 0.8 1.8 0.7
excretion mg/kg/day
History of renal 4 4 0
lithiasis
up < 0.001
those with normal renal function (Table 1). Patients with idio-
pathic hypercalciuria due to depressed renal tubular calcium
reabsorption also show increased serum PTH levels [14]. Renal
Ca wasting with tendency to hypocalcemia is the mechanism
invoked to explain parathyroid stimulation. On the other hand,
PTH enhances tubular Mg reabsorption [15] and hypomag-
nesemia stimulates PTH secretion [14]. Thus, both hypercalciuria
and hypomagnesemia probably induced a persistent stimulus for
PTH secretion in our patients.
Nephrocalcinosis is another fundamental finding in this syn-
drome. Sustained hypercalciuria, unresponsive to dietary mea-
sures and to thiazide diuretics, is very likely to have a fundamental
role in the development of this complication. In addition, low
urinary excretions of citrate, a well-known inhibitor of renal
lithiasis, were found in some of previously reported patients [3, 6].
Although we did not measure urinary citrate in our patients, three
of them (cases 1,2 and 3) were treated with oral citrate solutions
for prolonged periods. However, citrate administration did not
appear to have a clearly beneficial influence on the progression to
renal insufficiency.
Another hypothetical abnormality that could promote the
development of nephrocalcinosis in this syndrome might be its
association with medullary sponge kidneys (MSK). This possibility
is highlighted by the finding of typical ectatic collecting ducts,
characteristic of MSK, in the intravenous urographies of two
relatives with hypercalciuria and previous stone passage (Fig. 5).
Urographic abnormalities suggestive of MSK have also been
described in brothers of some previously reported cases [61.
Interestingly, MSK patients frequently show hypercalciuria and
nephrocalcinosis, some of them reaching advanced renal insuffi-
ciency [16]. Dilated collecting ducts are the nidus for calculi
formation in the presence of hypercalciuria and other possible
promoters of renal lithiasis. Well-contrasted intravenous urogra-
phy is the only diagnostic procedure to establish the diagnosis of
MSK. Although the association of hypomagnesemia, hypercalci-
uria and nephrocalcinosis syndrome with MSK is an intriguing
possibility, the presence of renal insufficiency in most of these
patients makes obtaining of demonstrative urographic images very
difficult.
Experimental studies have shown that Mg-deficiet rats fed high
Fig. 5. Intravenous urography of a members of family 3 (Fig. 4) with
hypercalciuria and previous renal lithiasis. Linear striations in the papillae
(more evident in right kidney) characteristic of medullary sponge kidney
are seen.
fructose diets develop nephrocalcinosis, through precipitation of
calcium phosphate in the cortico-medullary junction of the kid-
neys [17, 181. Stimulus of parathormone secretion by Mg defi-
ciency probably played an important role in this experimental
model of nephrocalcinosis. Renal calcification was considerably
more significant in female than in male rats; oestrogens favor
calcium phosphate precipitation in this model. Interestingly, a
female preponderance (6 of 8, Table 1) was observed in our
patients. The Mg-deficient rats showed hypercalcemia and hyper-
calciuria; however, they presented hypomagnesuria, in contrast
with the persistent hypermagnesuria of our patients.
Renal function worsened in all our patients (Fig. 3). Although
long-term follow-up of renal function was not described in
previously reported cases, most of them showed variable degrees
of renal insufficiency [1—81. The prolonged follow-up of our cases
allowed us to establish that progression to end-stage renal failure
is the rule in the majority of patients. Interestingly, the only two
cases (patients 1 and 8) with slower progression of renal failure, in
which chronic dialysis has not yet been started after prolonged
follow-up, showed mild isolated calcifications in their x-ray films
of abdomen, in contrast with the severe nephrocalcinosis of the six
other patients (Fig. 1). This different evolution strengthens the
importance of nephrocalcinosis in the progression of renal failure.
To the best of our knowledge, evolution after renal transplan-
tation has not been previously reported in this syndrome. Our five
patients receiving a kidney graft showed a persistent normality in
tubular handling of Mg and Ca, with normal values of serum Mg
and urinary Ca (Table 4). The normality of serum Mg persisted
throughout the post-transplant evolution, despite the fact that all
the five cases were treated with cyclosporine, a drug that can
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induce hypomagnesemia [19]. This normal handling of Mg and Ca
after renal transplantation strongly suggests the existence of a
defect in Mg and Ca absorption by renal tubules of the native
kidneys in our patients.
Extensive familial investigations have not been previously re-
ported in this entity. Our study of 26 relatives belonging to four of
the five affected families showed normal serum Mg levels and
absence of nephrocalcinosis or ocular abnormalities. By contrast,
a striking incidence of hypercalciuria was found; 11 out of 26
relatives (42%) had urinary Ca excretions higher than 4 mg/kg/day
(Table 5) and four of them had passed renal stones. Further
differences were not observed between hypercalciuric and normo-
calciuric relatives. The pedigrees of the four families studied are
shown in Figure 4. It could be speculated that isolated hypercal-
ciuria represents a milder clinical expression of the disease, the
syndrome of hypomagnesemia, hypercalciuria and nephrocalcino-
sis being the complete expression of this familial disorder. In this
case, an autosomal dominant inheritance with variable clinical
expression could be hypothesized. Further studies are needed in
order to investigate the genetic basis of this entity. In addition, the
association with ocular abnormalities and the possible relation-
ship with MSK are other interesting questions that require further
clinical and genetic studies.
Reprint requests to: Manuel Praga, Servicio de Nefrologia, Hospital 12 de
Octubre, Crta de AndalucIa Km 5.400, 28041 Madrid, Spain.
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